Does SEN-V and other non-A-E hepatotropic viruses contribute to the development and progression of non-alcoholic fatty liver disease?

Approximately 10–20% of patients with non-alcoholic fatty liver disease (NAFLD) are at risk of progressing to cirrhosis. The cause of such progression is unclear. SEN-V is a hepatotropic virus that has been associated with more severe and advanced liver disease in patients with chronic hepatitis C v...

Full description

Saved in:

Bibliographic Details
Published in:	Medical hypotheses Vol. 137; p. 109528
Main Authors:	Grubert Van Iderstine, M., Osiowy, C., Rumbolt, C., Zhang, M., Swidinsky, K., Kaita, K.D.E., Minuk, G.Y.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Ltd 01-04-2020
Subjects:	Disease Progression DNA Viruses Hepatitis C, Chronic - complications Humans Liver Cirrhosis Non-alcoholic Fatty Liver Disease Torque teno virus
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Approximately 10–20% of patients with non-alcoholic fatty liver disease (NAFLD) are at risk of progressing to cirrhosis. The cause of such progression is unclear. SEN-V is a hepatotropic virus that has been associated with more severe and advanced liver disease in patients with chronic hepatitis C virus infections. In this study we tested 32 NAFLD patients for evidence of SEN-V infection and correlated the results with histologic findings. The results of the study revealed similar disease severity and stage of progression in SEN-V positive and negative patients. Although not supportive of our hypothesis, the possibility that SEN-V and/or other non-A-E hepatotropic viruses contribute to the development and course of NAFLD is discussed.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0306-9877 1532-2777
DOI:	10.1016/j.mehy.2019.109528